Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Cardiovasc Diabetol

From Bioblast
Journals in Bioblast
Journal title and website Cardiovascular Diabetology

Publications

 ReferencePublishedView
Yurista 2020 Cardiovasc DiabetolYurista SR, Silljรฉ HHW, Rienstra M, de Boer RA, Westenbrink BD (2020) Sodium-glucose co-transporter 2 inhibition as a mitochondrial therapy for atrial fibrillation in patients with diabetes? Cardiovasc Diabetol 19:5.2020PMID: 31910841 Open Access
Shao 2019 Cardiovasc DiabetolShao Q, Meng L, Lee S, Tse G, Gong M, Zhang Z, Zhao J, Zhao Y, Li G, Liu T (2019) Empagliflozin, a sodium glucose co-transporter-2 inhibitor, alleviates atrial remodeling and improves mitochondrial function in high-fat diet/streptozotocin-induce diabetic rats. Cardiovasc Diabetol 18:165.2019PMID: 31779619 Open Access
Zhang 2018 Cardiovasc DiabetolZhang X, Zhang Z, Yang Y, Suo Y, Liu R, Qiu J, Zhao Y, Jiang N, Liu C, Tse G, Li G, Liu T (2018) Alogliptin prevents diastolic dysfunction and preserves left ventricular mitochondrial function in diabetic rabbits. Cardiovasc Diabetol 17:160.2018PMID: 30591063 Open Access
Hughey 2013 Cardiovasc DiabetolHughey CC, Ma L, James FD, Bracy DP, Wang Z, Wasserman DH, Rottman JN, Hittel DS, Shearer J (2013) Mesenchymal stem cell transplantation for the infarcted heart: therapeutic potential for insulin resistance beyond the heart. Cardiovasc Diabetol 12:128.2013PMID: 24007410 Open Access